Association Between Oral Corticosteroid Bursts and Severe Adverse Events: A Nationwide Population-Based Cohort Study
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background: Long-term use of oral corticosteroids has known adverse effects, but the risk from brief oral steroid bursts (≤14 days) is largely unknown. Objective: To examine the associations between steroid bursts and severe adverse events, specifically gastrointestinal (GI) bleeding, sepsis, and heart failure. Design: Self-controlled case series. Setting: Entire National Health Insurance Research Database of medical claims records in Taiwan. Participants: Adults aged 20 to 64 years with continuous enrollment in the National Health Insurance program from 1 January 2013 to 31 December 2015. Measurements: Incidence rates of severe adverse events in steroid burst users and non–steroid users, as well as incidence rate ratios (IRRs) for severe adverse events within 5 to 30 and 31 to 90 days after initiation of steroid therapy. Results: Of 15 859 129 adult participants, 2 623 327 who received a single steroid burst were included. The most common indications were skin disorders and respiratory tract infections. The incidence rates per 1000 person-years in steroid bursts were 27.1 (95% CI, 26.7 to 27.5) for GI bleeding, 1.5 (CI, 1.4 to 1.6) for sepsis, and 1.3 (CI, 1.2 to 1.4) for heart failure. Rates of GI bleeding (IRR, 1.80 [CI, 1.75 to 1.84]), sepsis (IRR, 1.99 [CI, 1.70 to 2.32]), and heart failure (IRR, 2.37 [CI, 2.13 to 2.63]) significantly increased within 5 to 30 days after steroid therapy initiation and attenuated during the subsequent 31 to 90 days. Limitation: Persons younger than 20 years or older than 64 years were not included. Conclusion: Oral corticosteroid bursts are frequently prescribed in the general adult population in Taiwan. The highest rates of GI bleeding, sepsis, and heart failure occurred within the first month after initiation of steroid therapy. Primary Funding Source: National Health Research Institutes, Ministry of Science and Technology of Taiwan, Chang Gung Medical Foundation, and Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While adrenal insufficiency is unlikely after short-term glucocorticoid therapy, clinicians should be aware that even short-term glucocorticoid treatment can lead to complications such as increased incidence of sepsis, gastrointestinal bleeding, thromboembolism, and fractures (66, 68).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [68]
Citations
Cites
Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350
Quan, H., Li, B., Couris, C. M., Fushimi, K., Graham, P., Hider, P., Januel, J.-M., & Sundararajan, V. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq433 · Cited by 5,843
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Waljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830
Tutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719
Self controlled case series methods: an alternative to standard epidemiological study designs
Petersen, I., Douglas, I., & Whitaker, H. (2016) · BMJ · doi:10.1136/bmj.i4515 · Cited by 525
Souverein, P. C., Berard, A., Van Staa, T. P., Cooper, C., Egberts, A. C. G., Leufkens, H. G. M., & Walker, B. R. (2004) · Heart · doi:10.1136/hrt.2003.020180 · Cited by 482
Clinical Pharmacology of Corticosteroids
Williams, D. M. (2018) · Respiratory Care · doi:10.4187/respcare.06314 · Cited by 460
The epidemiology of glucocorticoid-associated adverse events
McDonough, A. K., Curtis, J. R., & Saag, K. G. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f51031 · Cited by 405
Walsh, L. J., Wong, C. A., Pringle, M., & Tattersfield, A. E. (1996) · BMJ · doi:10.1136/bmj.313.7053.344 · Cited by 383
Relative Incidence Estimation from Case Series for Vaccine Safety Evaluation
Farrington, C. P. (1995) · Biometrics · doi:10.2307/2533328 · Cited by 367
Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
Narum, S., Westergren, T., & Klemp, M. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004587 · Cited by 327
Oral corticosteroid exposure and adverse effects in asthmatic patients
Sullivan, P. W., Ghushchyan, V. H., Globe, G., & Schatz, M. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.009 · Cited by 327
Volmer, T., Effenberger, T., Trautner, C., & Buhl, R. (2018) · European Respiratory Journal · doi:10.1183/13993003.00703-2018 · Cited by 322
Cushing, Cortisol, and Cardiovascular Disease
Whitworth, J. A., Mangos, G. J., & Kelly, J. J. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.912 · Cited by 259
Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention
Fardet, L., Kassar, A., Cabane, J., & Flahault, A. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00005 · Cited by 254
Is atherosclerosis a complication of long-term corticosteroid treatment?
Nashel, D. J. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90639-x · Cited by 181
Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
Waljee, A. K., Wiitala, W. L., Govani, S., Stidham, R., Saini, S., Hou, J., Feagins, L. A., Khan, N., Good, C. B., Vijan, S., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158017 · Cited by 176
Christiansen, C. F. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.297 · Cited by 120
Dix, D. B., Cellot, S., Price, V. E., Gillmeister, B., Ethier, M., Johnston, D. L., Lewis, V. A., Michon, B., Mitchell, D., Stobart, K., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis774 · Cited by 75
Gault, N., Castañeda-Sanabria, J., De Rycke, Y., Guillo, S., Foulon, S., & Tubach, F. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-016-0278-0 · Cited by 62
Investigating the assumptions of the self‐controlled case series method
Whitaker, H. J., Ghebremichael‐Weldeselassie, Y., Douglas, I. J., Smeeth, L., & Farrington, C. P. (2018) · Statistics in Medicine · doi:10.1002/sim.7536 · Cited by 59
Efraij, K. A., JOHNSON, K., Wiebe, D., Sadatsafavi, M., & FitzGerald, J. M. (2018) · Journal of Asthma · doi:10.1080/02770903.2018.1539100 · Cited by 54
Corticosteroids for sore throat: a clinical practice guideline
Aertgeerts, B., Agoritsas, T., Siemieniuk, R. A. C., Burgers, J. S., Bekkering, G. E., Merglen, A., van Driel, M., Vermandere, M., Bullens, D. M. A., Okwen, P., et al. (2017) · BMJ · doi:10.1136/bmj.j4090 · Cited by 23
The Risk of Sepsis with Inhaled and Oral Corticosteroids in Patients with COPD
Ernst, P., Coulombe, J., Brassard, P., & Suissa, S. (2016) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2016.1238450 · Cited by 21
Fuhlbrigge, A. L., Lemanske, R. F., Rasouliyan, L., Sorkness, C. A., & Fish, J. E. (2012) · Allergy and Asthma Proceedings · doi:10.2500/aap.2012.33.3499 · Cited by 14
Rogers, M. A. M., Lin, P., Nallamothu, B. K., Kim, C., & Waljee, A. K. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12631 · Cited by 13
Research works printed but not linked: 1
- Ebell MH, 2018, Am Fam Physician, 98, 12
Cited by
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Kalil, A. C., Patterson, T. F., Mehta, A. K., Tomashek, K. M., Wolfe, C. R., Ghazaryan, V., Marconi, V. C., Ruiz-Palacios, G. M., Hsieh, L., Kline, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031994 · Cited by 1,835
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae250 · Cited by 172
Pain management strategies in rheumatoid arthritis: a narrative review
Sánchez-Flórez, J. C., Seija-Butnaru, D., Valero, E. G., Acosta, C. D. P. A., & Amaya, S. (2021) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2021.1973647 · Cited by 54
“In addition, with the use of short cycles (≤14 days), increased rates of sepsis, venous embolism, fractures, gastrointestinal bleeding and heart failure have been reported up to 90 days after exposure (19, 21, 22).”
Background
Metadata
- Authors
- Yao, T.-C., Huang, Y.-W., Chang, S.-M., Tsai, S.-Y., Wu, A. C., & Tsai, H.-J.
- Affiliations
- Chang Gung University (TW)
- National Health Research Institutes (TW)
- National Cheng Kung University (TW)
- Boston Children's Hospital (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2020-09-01
- Volume
- 173
- Issue
- 5
- Pages
- 325-330
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W3038512297
- Cited by
- 0
- References
- 28
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- Funders
- NIH/ NICHD (1R01HD085993-01)
- National Health Research Institutes, Taiwan (PH-108-PP-08)
- Chang Gung Memorial Hospital, Linkou (CMRPG3J0121)
- Ministry of Science and Technology, Taiwan (MOST 107-2314-B-400-031-MY3, MOST 106-2314-B-182-051-MY3)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- oral corticosteroids, adverse drug reactions, gastrointestinal bleeding, sepsis, heart failure, drug safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.